Shetye Bharti, Hamilton Franchell Richard, Bays Harold Edward
Diplomate American Board of Obesity Medicine, Medical Director, Dr. Abby's Weight Management Clinic, 6101 Webb Road, Suite 207, Tampa, FL, 33615, USA.
Diplomate American Board of Obesity Medicine, A Better Weigh Center, 8865 Davis Blvd Ste 100, Keller, TX, 76248, USA.
Obes Pillars. 2022 Apr 1;2:100015. doi: 10.1016/j.obpill.2022.100015. eCollection 2022 Jun.
This Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) is intended to provide clinicians an overview of bariatric surgery (i.e., bariatric procedures that improve metabolic disease are often termed "metabolic and bariatric surgery"), gastrointestinal hormones, and the microbiome as they relate to patients with obesity.
The scientific information for this CPS is based upon published scientific citations, clinical perspectives of OMA authors, and peer review by the Obesity Medicine Association leadership.
This CPS includes the pros and cons of the most common types of bariatric procedures; the roles of gastrointestinal (GI) hormones in regulating hunger, digestion, and postabsorptive nutrient metabolism; and the microbiome's function and relationship with body weight. This CPS also describes patient screening for bariatric surgery, patient care after bariatric surgery, and treatment of potential nutrient deficiencies before and after bariatric surgery. Finally, this CPS explores the interactions between bariatric surgery, GI hormones, and the microbiome.
This Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) regarding bariatric surgery, gastrointestinal hormones, and the microbiome is one of a series of OMA CPSs designed to assist clinicians in the care of patients with the disease of obesity. Implementation of appropriate care before and after bariatric surgery, as well as an awareness of GI hormones and the microbiome, may improve the health of patients with obesity, especially patients with adverse fat mass and adiposopathic metabolic consequences.
本肥胖医学协会（OMA）临床实践声明（CPS）旨在为临床医生提供有关减肥手术（即改善代谢疾病的减肥手术通常被称为“代谢和减肥手术”）、胃肠激素以及微生物群与肥胖患者关系的概述。
本CPS的科学信息基于已发表的科学引文、OMA作者的临床观点以及肥胖医学协会领导层的同行评审。
本CPS包括最常见减肥手术类型的利弊；胃肠（GI）激素在调节饥饿、消化和吸收后营养物质代谢中的作用；以及微生物群的功能及其与体重的关系。本CPS还描述了减肥手术的患者筛查、减肥手术后的患者护理以及减肥手术前后潜在营养缺乏的治疗。最后，本CPS探讨了减肥手术、胃肠激素和微生物群之间的相互作用。
本肥胖医学协会（OMA）关于减肥手术、胃肠激素和微生物群的临床实践声明（CPS）是OMA一系列CPS之一，旨在帮助临床医生护理肥胖患者。在减肥手术前后实施适当的护理，以及了解胃肠激素和微生物群，可能会改善肥胖患者的健康状况，尤其是那些有不良脂肪量和脂肪病性代谢后果的患者。
